Learn more

PROCTER & GAMBLE PHARMA

Overview
  • Total Patents
    327
About

PROCTER & GAMBLE PHARMA has a total of 327 patent applications. Its first patent ever was published in 1987. It filed its patents most often in Israel, EPO (European Patent Office) and Norway. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are BARBEAU DONALD L, KESEL ANDREAS JOHANNES and ACAD OF SCIENCE CZECH REPUBLIC.

Patent filings per year

Chart showing PROCTER & GAMBLE PHARMAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Francis Marion David 78
#2 Ebetino Frank Hallock 70
#3 Kaas Susan Mary 48
#4 Yu Chia-Nien 45
#5 Ebetino Frank H 41
#6 Kaas Susan M 35
#7 Bayless Allan Vincent 25
#8 Dansereau Susan Mary 23
#9 Boyce Rogely Waite 23
#10 Pelosi Stanford Salvatore Jr 21

Latest patents

Publication Filing date Title
CN1224018A Phosphonic carboxylate compounds, pharmaceutical compositions contg. same
HU211676A9 Antimicrobial quinolonyl lactam esters
HU211319A9 Antimicrobial quinolone thioureas
HU211332A9 Antimicrobial dithiocarbamoyl quinolones
HU211973A9 Antimicrobial quinolonyl esters
US5783677A Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
CA2138366A1 Methods for the treatment of arthritis using phosphonates and nsaids
CA2138367A1 Use of phosphonates for the treatment of osteoporosis
IL119243A Phosphonocarboxylate compounds and pharmaceutical compositions containing them
EP0646119A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
AU4394693A Quaternary nitrogen-containing phosphonate for treating abnormal calcium and phosphate metabolism
AU4391793A Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
AU4391693A Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
RU94046138A Thio-substituted cyclic phosphonate compounds for treatment of anomal calcium and phosphate metabolism, pharmaceutical composition, method of treatment
AU4391993A Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
IL105714D0 Oral dosage forms of risedronate active ingredient
ZA9303337B Novel dosage forms of risedronate
CZ296694A3 Phosphonate compounds containing quaternary nitrogen atom and their use in a pharmaceutical preparation for treating abnormal calcium and phosphate metabolism
US5391743A Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
CN1089268A Utilize the 14-amino steroid to slow down the tempo of myocardial structural damages